caplacizumab
Term · Oncology and biomedicine · MLC-T-ONC-001392
A drug used with plasma exchange and immunosuppressive therapy to treat acquired thrombotic thrombocytopenic purpura (aTTP). aTTP is a rare blood disorder in which blood clots form in small blood vessels throughout the body. Caplacizumab binds to a protein called VWF, which may help keep blood clots from forming. It is a type of nanobody (a tiny antibody). Also called Cablivi.
| Identifier | MLC-T-ONC-001392 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Cablivi |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001392",
"term": "caplacizumab",
"field": "Oncology and biomedicine",
"definition": "A drug used with plasma exchange and immunosuppressive therapy to treat acquired thrombotic thrombocytopenic purpura (aTTP). aTTP is a rare blood disorder in which blood clots form in small blood vessels throughout the body. Caplacizumab binds to a protein called VWF, which may help keep blood clots from forming. It is a type of nanobody (a tiny antibody). Also called Cablivi.",
"synonyms": [
"Cablivi"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/caplacizumab/"
}
Record 4,115 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.